Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Details 3)

v3.23.3
Summary of Significant Accounting Policies (Details 3) - shares
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total common stock equivalents 2,626,071 2,709,523 2,647,820 2,709,523
Options Held [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total common stock equivalents 210,211 290,330 231,960 290,330
Warrant [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total common stock equivalents 2,415,860 2,419,193 2,415,860 2,419,193